Medicover to Buy €44.4M in NIPD Shares, Acquire Majority Stake
In 2018, NIPD struck a partnership deal with Medicover that included an equity investment and R&D cooperation.
NIPD Genetics Wins $1.5M From Cypriot Foundation to Develop Liquid Biopsy, PGT Assays
The Cyprus-based company has been offering a cell-free DNA-based noninvasive prenatal test for fetal aneuploidies, called Veracity, since 2015.
Last month, the Cyprus-based genetic diagnostics company launched a number of hereditary cancer and somatic tumor sequencing panels, its first tests for oncology.
Noninvasive Prenatal Diagnostic Test Agreement Reached by NIPD Genetics, Medicover
The companies will bring NIPD Genetics' Veracity and Veragene noninvasive prenatal tests to Medicover's markets, as well as developing new genetic tests.
Feb 9, 2017